Treatment outcomes of multidrug-resistant tuberculosis patients in Zhejiang, China, 2009–2013

Global tuberculosis report (2014)

L.A. Gabbasova, E.R. Experts Who · 2014 · 13.2K citations

Public Health, Infectious Diseases, Microbiology +12

Incidence of Serious Side Effects from First-Line Antituberculosis Drugs among Patients Treated for Active Tuberculosis

Daphne Yee, Chantal Valiquette, Marthe Pelletier et al. · American Journal of Respiratory and Critical Care Medicine · 2003 · 841 citations

Medicine, Pharmacology, Pharmacotherapy +15

National Survey of Drug-Resistant Tuberculosis in China

Yanlin Zhao, Shaofa Xu, Lixia Wang et al. · New England Journal of Medicine · 2012 · 645 citations · Full text

Public Health, Infectious Diseases, Preventive Medicine +15

Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis

T. Schaberg, K Rebhan, H. Lode · European Respiratory Journal · 1996 · 380 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study

Vaira Leimane, Vija Riekstiņa, Timothy H. Holtz et al. · The Lancet · 2005 · 271 citations

Public Health, Internal Medicine, Pharmacotherapy +17